Filtros : "China" "Illes, Peter" Removido: "Italiano" Limpar

Filtros



Limitar por data


  • Fonte: Purinergic Signalling. Unidades: ICB, IQ

    Assuntos: NEUROTRANSMISSORES, RECEPTORES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JUVENAL, Guilherme Araújo et al. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10034-x. Acesso em: 09 out. 2024.
    • APA

      Juvenal, G. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G. de, et al. (2024). Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling. doi:10.1007/s11302-024-10034-x
    • NLM

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 out. 09 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
    • Vancouver

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 out. 09 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
  • Fonte: Neurobiology of Disease. Unidade: IQ

    Assuntos: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 09 out. 2024.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 out. 09 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 out. 09 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Fonte: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Unidade: IQ

    Assuntos: NEURÔNIOS, SISTEMA NERVOSO CENTRAL

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAETANO, Roberta Andrejew et al. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 09 out. 2024.
    • APA

      Caetano, R. A., Turrini, N., Ye, Q., Tang, Y., Illes, P., & Ulrich, H. (2023). Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer.
    • NLM

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 out. 09 ]
    • Vancouver

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 out. 09 ]
  • Unidade: IQ

    Assuntos: RECEPTORES, NUCLEOTÍDEOS

    Como citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ULRICH, Henning e ILLES, Peter e GLASER, Talita. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. . Cham: Springer. . Acesso em: 09 out. 2024. , 2023
    • APA

      Ulrich, H., Illes, P., & Glaser, T. (2023). Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. Cham: Springer.
    • NLM

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 out. 09 ]
    • Vancouver

      Ulrich H, Illes P, Glaser T. Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration. 2023 ;[citado 2024 out. 09 ]
  • Fonte: Signal Transduction and Targeted Therapy. Unidade: IQ

    Assuntos: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 09 out. 2024.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 out. 09 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 out. 09 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
  • Fonte: Purinergic Signalling. Unidade: IQ

    Assuntos: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 09 out. 2024.
    • APA

      Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
    • NLM

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
    • Vancouver

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
  • Fonte: Neuroscience Bulletin. Unidade: IQ

    Assuntos: ANALGÉSICOS, DOR

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REN, Wen-Jing et al. TASK-3: new target for pain-relief. Neuroscience Bulletin, v. 36, n. 8, p. 951–954, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00516-4. Acesso em: 09 out. 2024.
    • APA

      Ren, W. -J., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2020). TASK-3: new target for pain-relief. Neuroscience Bulletin, 36( 8), 951–954. doi:10.1007/s12264-020-00516-4
    • NLM

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
    • Vancouver

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
  • Fonte: Neuroscience Bulletin. Unidade: IQ

    Assuntos: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 09 out. 2024.
    • APA

      Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
    • NLM

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
    • Vancouver

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s12264-020-00582-8

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024